Table I. Functional enrichments in CLU protein-protein interaction network as determined by STRING analysis (Top 5).
Biological process (GO) | Count in gene set | FDR | |
---|---|---|---|
Regulation of proteolysis | 9 | 1.25e-08 | |
2 | Humoral immune response | 7 | 1.46E-08 |
3 | Platelet degranulation | 6 | 2.04E-08 |
4 | Complement activation, classical pathway | 4 | 1.40E-06 |
5 | Regulation of protein activation cascade | 4 | 3.68e-06 |
Molecular function (GO) | Count in gene set | FDR | |
---|---|---|---|
1 | Receptor activator activity | 2 | 0.0029 |
2 | Growth factor receptor binding | 3 | 0.0033 |
3 | Low-density lipoprotein particle receptor binding | 2 | 0.0035 |
4 | Heparin binding | 3 | 0.0035 |
5 | Chemoattractant activity | 2 | 0.0037 |
Cellular component (GO) | Count in gene set | FDR | |
---|---|---|---|
1 | Platelet alpha granule lumen | 6 | 2.12e-10 |
2 | Secretory granule lumen | 7 | 7.39e-09 |
3 | Extracellular region | 11 | 7.59e-09 |
4 | Membrane attack complex | 3 | 4.42e-07 |
5 | Extracellular space | 7 | 1.07e-05 |
KEGG pathways | Count in gene set | FDR | |
---|---|---|---|
1 | Complement and coagulation cascades | 4 | 4.34e-06 |
2 | Systemic lupus erythematosus | 4 | 4.46e-06 |
3 | Prion diseases | 3 | 1.46e-05 |
4 | Amoebiasis | 3 | 0.00022 |
5 | Focal adhesion | 3 | 0.0015 |